Hem › Ulcerös kolit › Illinois › Chicago
Kliniska studier för Ulcerös kolit i Chicago, IL
15 studier för Ulcerös kolit söker deltagare vid platser i och runt Chicago (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
RekryterarFas 3
- University of Chicago Medical Center /ID# 271588, Chicago
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RekryterarFas 2
- Northwestern University, Chicago
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RekryterarFas 2
- Site 038, Chicago
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RekryterarFas 2
- University of Chicago Medical Center, Chicago
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RekryterarFas 3
- Rush University Medical Center, Chicago
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
RekryterarFas 2
- Northwestern University, Chicago
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
RekryterarFas 2
- Rush University Medical Center, Chicago
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
RekryterarFas 2
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
RekryterarFas 4
- University of Chicago Medicine, Chicago
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RekryterarFas 3
- Rush University Medical Center - Site Number: 8400015, Chicago
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Rekryterar
- University of Chicago Medicine, Chicago
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
RekryterarObservationsstudie
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
RekryterarFas 2
- University of Chicago Medical Center, Chicago
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
RekryterarFas 2
- Northwestern University, Chicago
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
Rekryterar
- University of Chicago, Chicago
Ulcerös kolit-studier i andra städer
- New York City, NY23 studier
- Orlando, FL22 studier
- Miami, FL21 studier
- Houston, TX17 studier
- San Antonio, TX16 studier
- Tacoma, WA15 studier
- San Diego, CA15 studier
- Tyler, TX14 studier
- Colorado Springs, CO14 studier
- Los Angeles, CA13 studier
- St. Louis, MO13 studier
- Washington, DC12 studier
Andra studier i Chicago
- Icke-småcellig lungcancer61 studier
- Bröstcancer58 studier
- Cancer (alla typer)51 studier
- Metastaserande cancer45 studier
- Prostatacancer45 studier
- Övervikt41 studier
- Lungcancer41 studier
- Äggstockscancer36 studier
- Stroke34 studier
- Kolorektal cancer33 studier
- Hjärtsvikt31 studier
- Övervikt28 studier
Från ClinicalTrials.gov, data hämtad 4 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.